About: Regional, age and respiratory-secretion-specific prevalence of respiratory viruses associated with asthma exacerbation: a literature review

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Regional, age and respiratory-secretion-specific prevalence of respiratory viruses associated with asthma exacerbation: a literature review Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Regional, age and respiratory-secretion-specific prevalence of respiratory viruses associated with asthma exacerbation: a literature review
Creator	Guan, Wei-Jie Zheng, Xue-Yan Li, · Lin, -Feng Xu, Yan-Jun
source	Medline; PMC
abstract	Despite increased understanding of how viral infection is involved in asthma exacerbations, it is less clear which viruses are involved and to what extent they contribute to asthma exacerbations. Here, we sought to determine the prevalence of different respiratory viruses during asthma exacerbations. Systematic computerized searches of the literature up to June 2017 without language limitation were performed. The primary focus was on the prevalence of respiratory viruses, including AdV (adenovirus), BoV (bocavirus), CoV (coronavirus), CMV (cytomegalovirus), EnV (enterovirus), HSV (herpes simplex virus), IfV (influenza virus), MpV (metapneumovirus), PiV (parainfluenzavirus), RV (rhinovirus) and RSV (respiratory syncytial virus) during asthma exacerbations. We also examined the prevalence of viral infection stratified by age, geographic region, type of respiratory secretion, and detection method. Sixty articles were included in the final analysis. During asthma exacerbations, the mean prevalence of AdV, BoV, CoV, CMV, EnV, HSV, IfV, MpV, PiV, RV and RSV was 3.8%, 6.9%, 8.4%, 7.2%, 10.1%, 12.3%, 10.0%, 5.3%, 5.6%, 42.1% and 13.6%, respectively. EnV, MPV, RV and RSV were more prevalent in children, whereas AdV, BoV, CoV, IfV and PiV were more frequently present in adults. RV was the major virus detected globally, except in Africa. RV could be detected in both the upper and lower airway. Polymerase chain reaction was the most sensitive method for detecting viral infection. Our findings indicate the need to develop prophylactic polyvalent or polyvirus (including RV, EnV, IfV and RSV) vaccines that produce herd immunity and reduce the healthcare burden associated with virus-induced asthma exacerbations. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00705-017-3700-y) contains supplementary material, which is available to authorized users.
has issue date	2018-01-11(xsd:dateTime)
bibo:doi	10.1007/s00705-017-3700-y
bibo:pmid	29327237
has license	no-cc
sha1sum (hex)	fe4bf322be214e87e13134ec352d82c40318d598
schema:url	https://doi.org/10.1007/s00705-017-3700-y
resource representing a document's title	Regional, age and respiratory-secretion-specific prevalence of respiratory viruses associated with asthma exacerbation: a literature review
has PubMed Central identifier	PMC7087223
has PubMed identifier	29327237
schema:publication	Arch Virol
resource representing a document's body	covid:fe4bf322be214e87e13134ec352d82c40318d598#body_text
is schema:about of	named entity 'ASSOCIATED WITH' named entity 'final analysis' named entity 'RSV' named entity 'Despite' named entity 'Polymerase chain reaction' named entity 'RSV' named entity 'IfV' named entity 'limitation' named entity 'asthma' named entity 'viruses' named entity 'exacerbation' named entity 'SECRETION' named entity 'CMV' named entity 'SIMPLEX' named entity 'VIRUS' named entity 'METHOD' named entity 'SYNCYTIAL' named entity 'DIFFERENT' named entity 'RSV' named entity 'POLYMERASE CHAIN REACTION' named entity 'TYPE' named entity 'FINDINGS' named entity 'WHAT' named entity 'ADV' named entity 'HOW' named entity 'HSV' named entity 'DETECTED' named entity 'LOWER AIRWAY' named entity 'CONTRIBUTE ' named entity 'INDUCED' named entity '7.2' named entity 'ASSOCIATED WITH' named entity '6.9' named entity 'REDUCE' named entity 'UNDERSTANDING' named entity '5.6' named entity 'MPV' named entity 'NEED' covid:arg/fe4bf322be214e87e13134ec352d82c40318d598 named entity 'HERE' named entity 'INVOLVED' named entity 'INCLUDING' named entity 'INCREASED' named entity 'ANALYSIS' named entity 'FINAL' named entity 'SENSITIVE' named entity 'DETECTION METHOD' named entity 'STRATIFIED' named entity 'AFRICA' named entity 'MAJOR' named entity 'UP TO' named entity 'CHILDREN' named entity 'ASTHMA EXACERBATIONS' named entity '12.3' named entity '8.4' named entity 'RESPIRATORY VIRUSES' named entity 'SPECIFIC' named entity 'PRODUCE' named entity 'EXTENT' named entity 'LITERATURE REVIEW' named entity 'ASTHMA EXACERBATION' named entity 'REGIONAL' named entity 'PREVALENCE' named entity 'AGE' named entity 'LITERATURE' named entity 'RESPIRATORY SECRETION' named entity 'EXCEPT' named entity 'SIXTY' named entity 'AGE' named entity 'LANGUAGE' named entity 'VACCINES' named entity 'DETECTING' named entity 'UPPER' named entity 'PRIMARY FOCUS' named entity 'PROPHYLACTIC' named entity 'PRESENT' named entity 'GEOGRAPHIC REGION'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software